NCT05131841 2021-11-23
Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC
Zhejiang Cancer Hospital
Phase 4 Unknown
Zhejiang Cancer Hospital
Peking University
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Hoffmann-La Roche
Tianjin Medical University Cancer Institute and Hospital